Skip to main content
Premium Trial:

Request an Annual Quote

Bruker Daltonics Inks Biomarker Discovery Deal with SurroMed

NEW YORK, Dec. 1 (GenomeWeb News) - Bruker Daltonics, a unit of Bruker BioSciences, has entered a partnership under which its microTOF ESI-TOF mass spectrometers will be used in SurroMed's biomarker discovery laboratory, the companies said today.


The deal also calls for the companies to collaborate on developing software and sample fractionation products. Additional terms were not disclosed.


"In conjunction with SurroMed's proprietary MassView software, [Bruker's mass spectrometry] instruments will allow us to increase substantially the number of proteins, peptides, and metabolites that we are able to identify and quantify from our samples," Christopher Becker, SurroMed's director of chemistry, said in a statement.



The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.